Commentary, follow the money, Health Care, News

Drug companies are sitting on generics—43% of recently approved aren’t for sale | Ars Technica

Posted on by johnbarleycorn12

You pay more for medicine because hundreds of generics aren’t for sale.
— Read on arstechnica.com/science/2019/02/drug-companies-are-sitting-on-generics-43-of-recently-approved-arent-for-sale/

Big pharma again.

Leave a comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.